The progression from MGUS to active MM is associated with alterations in Tregs and terminal effector CD8+ T cells (TTEs) and is correlated with reduced survival in patients with recent MM diagnosis [1]. The gene discussed is CD8A; the disease is Miyoshi myopathy.